APA način citiranja

Dai, S., Yan, Y., Xu, Z., Zeng, S., Qian, L., Huo, L., . . . Gong, Z. (2019). Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis. Front Pharmacol.

Čikaški stil citiranja

Dai, Shuang, Yuanliang Yan, Zhijie Xu, Shuangshuang Zeng, Long Qian, Lei Huo, Xuejun Li, Lunquan Sun, i Zhicheng Gong. "Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis." Front Pharmacol 2019.

MLA način citiranja

Dai, Shuang, et al. "Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis." Front Pharmacol 2019.